J&J may not meet US Covid-19 vaccine supply target by spring
Earlier this week, J&J's chief executive officer said the company was on track to have close to a billion Covid-19 vaccine doses by 2021-end
Earlier this week, J&J's chief executive officer said the company was on track to have close to a billion Covid-19 vaccine doses by 2021-end